Omnicell vs its peers
The 7 largest Health Care Technology companies by market value, prices of Nov 20, 2026
Omnicell is the 6th largest of the 7 biggest Health Care Technology companies on OQRO by market value, at $1.5B. Its revenue of $1.18B in fiscal 2025 ranks 3rd of 7. It keeps 0% of revenue as operating profit, the lowest of the group (median 23%). Revenue grew 7% on the year before, against a median of +8.7%. At 729x its latest annual earnings, the market prices it above its peers (median 43.9x).
Side by side
| Company | Market value | Revenue | Growth y/y | 5-yr growth / yr | Gross margin | Operating margin | Net margin | Free cash flow margin | R&D / revenue | Price / earnings | Price / sales | FCF yield | Stock, 12 months |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Veeva SystemsVEEV · FY2026 | $43.1B | $3.2B | +16.3% | +16.9% | 75.5% | 28.7% | 28.4% | — | 24.0% | 47.4x | 13.5x | — |
Each company’s latest fiscal year (FY), so the years can end a few months apart. Price ratios divide today’s market value by that year’s figure; price / earnings is left out on a loss. “—” means the company did not tag that line in its annual report.
Operating margin
- DOCS33%
- VEEV29%
- SOLV26%
- WAY23%
- HSTM7%
- CERT5%
- OMCL0%
Revenue growth, latest year
- WAY+16.5%
- VEEV
Compare Omnicell head to head
Where Omnicell’s revenue comes from and where it goes: Omnicell revenue breakdown. Twenty years of results: Omnicell financial history.
Common questions
Who are Omnicell's competitors?
The largest companies in its industry (Health Care Technology) by market value: Veeva Systems (VEEV), Solventum (SOLV), Doximity (DOCS), Waystar Holding Corp (WAY), Certara, Inc. (CERT) and HealthStream, Inc. (HSTM). They share Omnicell's industry listing; not every one competes with it on every product.
Is Omnicell bigger than Veeva Systems?
No, by market value: Omnicell is worth $1.5B and Veeva Systems $43.1B. By revenue, Omnicell brought in $1.18B in fiscal 2025 and Veeva Systems $3.2B in fiscal 2026.
How does Omnicell's valuation compare with its peers?
Omnicell trades at 1.3x its annual revenue and 729x its net income. The median of the other 6 companies is 4.2x revenue and 43.9x earnings. A higher ratio means investors pay more for each dollar the company makes today, usually because they expect it to grow faster.
Where these figures come from
The group is the companies OQRO lists in the same industry as Omnicell (Health Care Technology), the largest 6 by market value, plus Omnicell. Companies whose latest annual report is more than a year and a half old, or that report in a currency other than the dollar, are left out.
Revenue, operating income, net income, gross profit, research and development and free cash flow (cash from operations minus capital expenditure) are each company’s own full-year lines from its latest 10-K, as tagged in XBRL (SEC companyfacts). Market value is the last close times the shares outstanding on the latest filing. Price / earnings is market value over net income; price / sales is market value over revenue; free cash flow yield is free cash flow over market value. Five-year growth is the yearly rate that takes revenue from five fiscal years before to the latest. This page describes the past and is not investment advice. No language model wrote it.






